发明名称 |
Novel anti-IGF-IR antibodies and uses thereof |
摘要 |
<p>The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor (IGF-IR). The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR, stimulated either by IGF1 and/or IGF2, or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR and/or the IGF-I / Insulin hybrid receptor.</p> |
申请公布号 |
EP2380913(A1) |
申请公布日期 |
2011.10.26 |
申请号 |
EP20110161901 |
申请日期 |
2006.07.21 |
申请人 |
PIERRE FABRE MEDICAMENT |
发明人 |
GOETSCH, LILIANE;CORVAIA, NATHALIE |
分类号 |
C07K16/28;A01K67/027;A61K39/395;A61P35/00;C07K16/46;C12N5/20;C12N15/13;C12N15/63;C12P21/08;G01N33/53 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|